ID   ATF4_RAT                Reviewed;         347 AA.
AC   Q9ES19;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-OCT-2024, entry version 160.
DE   RecName: Full=Cyclic AMP-dependent transcription factor ATF-4;
DE            Short=cAMP-dependent transcription factor ATF-4;
DE   AltName: Full=Activating transcription factor 4 {ECO:0000303|PubMed:10924501};
DE            Short=rATF-4 {ECO:0000303|PubMed:10924501};
GN   Name=Atf4 {ECO:0000303|PubMed:10924501, ECO:0000312|RGD:621863};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH GABBR1 AND GABBR2, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=10924501; DOI=10.1074/jbc.m002727200;
RA   Nehring R.B., Horikawa H.P.M., El Far O., Kneussel M., Brandstatter J.H.,
RA   Stamm S., Wischmeyer E., Betz H., Karschin A.;
RT   "The metabotropic GABAB receptor directly interacts with the activating
RT   transcription factor 4.";
RL   J. Biol. Chem. 275:35185-35191(2000).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=8506317; DOI=10.1073/pnas.90.10.4679;
RA   Vallejo M., Ron D., Miller C.P., Habener J.F.;
RT   "C/ATF, a member of the activating transcription factor family of DNA-
RT   binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs
RT   their binding to cAMP response elements.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4679-4683(1993).
CC   -!- FUNCTION: Transcription factor that binds the cAMP response element
CC       (CRE) (consensus: 5'-GTGACGT[AC][AG]-3') and displays two biological
CC       functions, as regulator of metabolic and redox processes under normal
CC       cellular conditions, and as master transcription factor during
CC       integrated stress response (ISR) (By similarity). Binds to asymmetric
CC       CRE's as a heterodimer and to palindromic CRE's as a homodimer (By
CC       similarity). Core effector of the ISR, which is required for adaptation
CC       to various stress such as endoplasmic reticulum (ER) stress, amino acid
CC       starvation, mitochondrial stress or oxidative stress. During ISR, ATF4
CC       translation is induced via an alternative ribosome translation re-
CC       initiation mechanism in response to EIF2S1/eIF-2-alpha phosphorylation,
CC       and stress-induced ATF4 acts as a master transcription factor of
CC       stress-responsive genes in order to promote cell recovery (By
CC       similarity). Promotes the transcription of genes linked to amino acid
CC       sufficiency and resistance to oxidative stress to protect cells against
CC       metabolic consequences of ER oxidation (By similarity). Activates the
CC       transcription of NLRP1, possibly in concert with other factors in
CC       response to ER stress. Activates the transcription of asparagine
CC       synthetase (ASNS) in response to amino acid deprivation or ER stress.
CC       However, when associated with DDIT3/CHOP, the transcriptional
CC       activation of the ASNS gene is inhibited in response to amino acid
CC       deprivation (By similarity). Together with DDIT3/CHOP, mediates
CC       programmed cell death by promoting the expression of genes involved in
CC       cellular amino acid metabolic processes, mRNA translation and the
CC       terminal unfolded protein response (terminal UPR), a cellular response
CC       that elicits programmed cell death when ER stress is prolonged and
CC       unresolved (By similarity). Together with DDIT3/CHOP, activates the
CC       transcription of the IRS-regulator TRIB3 and promotes ER stress-induced
CC       neuronal cell death by regulating the expression of BBC3/PUMA in
CC       response to ER stress. May cooperate with the UPR transcriptional
CC       regulator QRICH1 to regulate ER protein homeostasis which is critical
CC       for cell viability in response to ER stress (By similarity). In the
CC       absence of stress, ATF4 translation is at low levels and it is required
CC       for normal metabolic processes such as embryonic lens formation, fetal
CC       liver hematopoiesis, bone development and synaptic plasticity (By
CC       similarity). Acts as a regulator of osteoblast differentiation in
CC       response to phosphorylation by RPS6KA3/RSK2: phosphorylation in
CC       osteoblasts enhances transactivation activity and promotes expression
CC       of osteoblast-specific genes and post-transcriptionally regulates the
CC       synthesis of Type I collagen, the main constituent of the bone matrix
CC       (By similarity). Cooperates with FOXO1 in osteoblasts to regulate
CC       glucose homeostasis through suppression of beta-cell production and
CC       decrease in insulin production. Activates transcription of SIRT4.
CC       Regulates the circadian expression of the core clock component PER2 and
CC       the serotonin transporter SLC6A4. Binds in a circadian time-dependent
CC       manner to the cAMP response elements (CRE) in the SLC6A4 and PER2
CC       promoters and periodically activates the transcription of these genes.
CC       Mainly acts as a transcriptional activator in cellular stress
CC       adaptation, but it can also act as a transcriptional repressor: acts as
CC       a regulator of synaptic plasticity by repressing transcription, thereby
CC       inhibiting induction and maintenance of long-term memory (By
CC       similarity). Regulates synaptic functions via interaction with DISC1 in
CC       neurons, which inhibits ATF4 transcription factor activity by
CC       disrupting ATF4 dimerization and DNA-binding (By similarity).
CC       {ECO:0000250|UniProtKB:P18848, ECO:0000250|UniProtKB:Q06507}.
CC   -!- SUBUNIT: Binds DNA as a homodimer and as a heterodimer. Heterodimer;
CC       heterodimerizes with CEBPB. Heterodimer; heterodimerizes with
CC       DDIT3/CHOP. Interacts with CEP290 (via an N-terminal region). Interacts
CC       with NEK6, DAPK2 (isoform 2) and ZIPK/DAPK3 (By similarity). Interacts
CC       (via its leucine zipper domain) with GABBR1 and GABBR2 (via their C-
CC       termini) (PubMed:10924501). Forms a heterodimer with TXLNG in
CC       osteoblasts (By similarity). Interacts (via its DNA binding domain)
CC       with FOXO1 (C-terminal half); the interaction occurs in osteoblasts and
CC       regulates glucose homeostasis through suppression of beta-cell
CC       proliferation and a decrease in insulin production. Interacts with
CC       SATB2; the interaction results in enhanced DNA binding and
CC       transactivation by these transcription factors (By similarity).
CC       Interacts with ABRAXAS2 (By similarity). Interacts with TRIB3,
CC       inhibiting the transactivation activity of ATF4. Interacts with DISC1;
CC       which inhibits ATF4 transcription factor activity by disrupting ATF4
CC       dimerization and DNA-binding (By similarity). Interacts with
CC       EP300/p300; EP300/p300 stabilizes ATF4 and increases its
CC       transcriptional activity independently of its catalytic activity by
CC       preventing its ubiquitination (By similarity).
CC       {ECO:0000250|UniProtKB:P18848, ECO:0000250|UniProtKB:Q06507,
CC       ECO:0000269|PubMed:10924501}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10924501}. Nucleus
CC       speckle {ECO:0000250|UniProtKB:P18848}. Cytoplasm
CC       {ECO:0000269|PubMed:10924501}. Cell membrane
CC       {ECO:0000269|PubMed:10924501}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:P18848}.
CC       Note=Colocalizes with GABBR1 in hippocampal neuron dendritic membranes
CC       (PubMed:10924501). Colocalizes with NEK6 at the centrosome. Recruited
CC       to nuclear speckles following interaction with EP300/p300 (By
CC       similarity). {ECO:0000250|UniProtKB:P18848,
CC       ECO:0000269|PubMed:10924501}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, heart, liver, spleen, lung and
CC       muscle, but not testis. {ECO:0000269|PubMed:8506317}.
CC   -!- DOMAIN: The BetaTrCP degron motif promotes binding to BTRC when
CC       phosphorylated. {ECO:0000250|UniProtKB:P18848}.
CC   -!- PTM: Ubiquitinated by SCF(BTRC) in response to mTORC1 signal, followed
CC       by proteasomal degradation and leading to down-regulate expression of
CC       SIRT4. Interaction with EP300/p300 inhibits ubiquitination by
CC       SCF(BTRC). {ECO:0000250|UniProtKB:P18848}.
CC   -!- PTM: Phosphorylation at Ser-243 by RPS6KA3/RSK2 in osteoblasts enhances
CC       transactivation activity and promotes osteoblast differentiation (By
CC       similarity). Phosphorylated on the betaTrCP degron motif at Ser-217,
CC       followed by phosphorylation at Thr-211, Ser-222, Ser-229, Ser-233 and
CC       Ser-246, promoting interaction with BTRC and ubiquitination.
CC       Phosphorylation is promoted by mTORC1 (By similarity). Phosphorylation
CC       at Ser-213 by CK2 decreases its stability. Phosphorylated by NEK6 (By
CC       similarity). {ECO:0000250|UniProtKB:P18848,
CC       ECO:0000250|UniProtKB:Q06507}.
CC   -!- PTM: Hydroxylated by PHD3, leading to decreased protein stability.
CC       {ECO:0000250|UniProtKB:P18848}.
CC   -!- SIMILARITY: Belongs to the bZIP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF252627; AAG31732.1; -; mRNA.
DR   RefSeq; NP_077379.1; NM_024403.2.
DR   AlphaFoldDB; Q9ES19; -.
DR   SMR; Q9ES19; -.
DR   BioGRID; 249453; 2.
DR   IntAct; Q9ES19; 1.
DR   STRING; 10116.ENSRNOP00000060302; -.
DR   PhosphoSitePlus; Q9ES19; -.
DR   PaxDb; 10116-ENSRNOP00000060302; -.
DR   ABCD; Q9ES19; 1 sequenced antibody.
DR   DNASU; 79255; -.
DR   Ensembl; ENSRNOT00000065304.5; ENSRNOP00000060302.1; ENSRNOG00000017801.8.
DR   GeneID; 79255; -.
DR   KEGG; rno:79255; -.
DR   UCSC; RGD:621863; rat.
DR   AGR; RGD:621863; -.
DR   CTD; 468; -.
DR   RGD; 621863; Atf4.
DR   eggNOG; KOG4571; Eukaryota.
DR   GeneTree; ENSGT00530000063801; -.
DR   HOGENOM; CLU_055748_1_0_1; -.
DR   InParanoid; Q9ES19; -.
DR   OMA; WMTEKID; -.
DR   OrthoDB; 4843682at2759; -.
DR   PhylomeDB; Q9ES19; -.
DR   PRO; PR:Q9ES19; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000017801; Expressed in pancreas and 20 other cell types or tissues.
DR   ExpressionAtlas; Q9ES19; baseline and differential.
DR   GO; GO:1990590; C:ATF1-ATF4 transcription factor complex; ISO:RGD.
DR   GO; GO:1990589; C:ATF4-CREB1 transcription factor complex; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:1990617; C:CHOP-ATF4 complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:1990037; C:Lewy body core; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0034399; C:nuclear periphery; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:RGD.
DR   GO; GO:0140296; F:general transcription initiation factor binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043522; F:leucine zipper domain binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISS:UniProtKB.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; ISS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:1990253; P:cellular response to leucine starvation; ISO:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0034644; P:cellular response to UV; ISS:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; ISO:RGD.
DR   GO; GO:0035162; P:embryonic hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:RGD.
DR   GO; GO:0006094; P:gluconeogenesis; ISO:RGD.
DR   GO; GO:0140468; P:HRI-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0140467; P:integrated stress response signaling; ISS:UniProtKB.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0070982; P:L-asparagine metabolic process; ISO:RGD.
DR   GO; GO:0070309; P:lens fiber cell morphogenesis; ISS:UniProtKB.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:1903377; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0032057; P:negative regulation of translational initiation in response to stress; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0070169; P:positive regulation of biomineral tissue development; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:2000120; P:positive regulation of sodium-dependent phosphate transport; ISO:RGD.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1905461; P:positive regulation of vascular associated smooth muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:1990737; P:response to manganese-induced endoplasmic reticulum stress; IEP:ParkinsonsUK-UCL.
DR   GO; GO:0031667; P:response to nutrient levels; ISO:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd14692; bZIP_ATF4; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   PANTHER; PTHR13044; ACTIVATING TRANSCRIPTION FACTOR ATF 4/5; 1.
DR   PANTHER; PTHR13044:SF2; CYCLIC AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-4; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Biological rhythms; Cell membrane; Cytoplasm;
KW   Cytoskeleton; DNA-binding; Hydroxylation; Isopeptide bond; Membrane;
KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..347
FT                   /note="Cyclic AMP-dependent transcription factor ATF-4"
FT                   /id="PRO_0000258022"
FT   DOMAIN          274..337
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          202..296
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          276..296
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          301..337
FT                   /note="Interaction with GABBR1"
FT                   /evidence="ECO:0000269|PubMed:10924501"
FT   REGION          302..330
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   MOTIF           213..222
FT                   /note="BetaTrCP degron motif"
FT                   /evidence="ECO:0000250|UniProtKB:P18848"
FT   COMPBIAS        215..239
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        240..257
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        269..296
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         211
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P18848"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         234
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         246
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         307
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P18848"
FT   CROSSLNK        256
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P18848"
FT   CROSSLNK        268
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P18848"
SQ   SEQUENCE   347 AA;  38152 MW;  CCE6BD02F263296B CRC64;
     MTEMSFLNSE VLAGDLMSPF DQSGLGAEES LGLLDDYLEV AKHFKPHGFS SDKAGSSEWL
     AMDGLVSASD TGKEDAFSGT DWMLEKMDLK EFDFDALFRM DDLETMPDEL LATLDDTCDL
     FAPLVQETNK EPPQTVNPIG HLPESVIKVD QAAPFTFLQP LPCSPGFLSS TPDHSFSLEL
     GSEVDISEGD RKPDSAAYIT LTPQCVKEED TPSDSDSGIC MSPESYLGSP QHSPSTSRAP
     PDSLPSPGVP RGSRPKPYDP PGVSVTAKVK TEKLDKKLKK MEQNKTAATR YRQKKRAEQE
     ALTGECKELE KKNEALKEKA DSLAKEIQYL KDLIEEVRKA RGKKRVP
//
